Cargando…

Neurotrophic Keratopathy Treated with Topical Recombinant Human Nerve Growth Factor (Cenegermin): Case Series Study with Long-Term Follow-Up

The authors report the use of topical recombinant human nerve growth factor cenegermin 0.02% in 5 patients diagnosed with neurotrophic keratopathy (NK) in a real-life setting. These 5 patients affected with stage II and III NK mainly of herpetic cause received cenegermin six times daily for 8 weeks....

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Delpech, Salvador, Udaondo, Patricia, Fernández-Santodomingo, Alex Samir, García-Teillard, Damian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459538/ https://www.ncbi.nlm.nih.gov/pubmed/36160492 http://dx.doi.org/10.1159/000525923

Ejemplares similares

Neurotrophic keratopathy: Clinical presentation and effects of cenegermin
por: Bu, Julia Bing, et al.
Publicado: (2022)

Resolution of a neurotrophic keratopathy associated hypopyon with cenegermin
por: Zambino, Nick, et al.
Publicado: (2021)

Eight months follow-up of corneal nerves and sensitivity after treatment with cenegermin for neurotrophic keratopathy
por: Pedrotti, Emilio, et al.
Publicado: (2022)

Topical human recombinant nerve growth factor for stage 1 Neurotrophic Keratitis: Retrospective case series of cenegermin treatment
por: Epitropoulos, Alice T., et al.
Publicado: (2022)

Observational study of cenegermin for the treatment of limbal stem cell deficiency associated with neurotrophic keratopathy
por: Arboleda, Alejandro, et al.
Publicado: (2022)

A case report of pediatric neurotrophic keratopathy in pontine tegmental cap dysplasia treated with cenegermin eye drops
por: Fausto, Riccardo, et al.
Publicado: (2020)

A Novel Treatment for Neurotrophic Corneal Ulcer Using Topical Cenegermin (OXERVATE™) Containing Recombinant Human Nerve Growth Factor
por: Ahuja, Abhimanyu S, et al.
Publicado: (2020)

Long-term clinical outcome and satisfaction survey in patients with neurotrophic keratopathy after treatment with cenegermin eye drops or amniotic membrane transplantation
por: Sacchetti, Marta, et al.
Publicado: (2021)

Update On Cenegermin Eye Drops In The Treatment Of Neurotrophic Keratitis
por: Sheha, Hosam, et al.
Publicado: (2019)

Use of Tachosil(®) as an adjuvant therapeutic option in neurotrophic keratopathy in order to prevent perforation
por: Rahhal-Ortuño, Miriam, et al.
Publicado: (2019)

Effect of recombinant human nerve growth factor treatment on corneal nerve regeneration in patients with neurotrophic keratopathy
por: Balbuena-Pareja, Ana, et al.
Publicado: (2023)

Role of Topical Cenegermin in Management of a Cornea Transplant in a Functionally Monocular Patient with Neurotrophic Keratitis and Facial Nerve Palsy: A Case Report
por: Pocobelli, Augusto, et al.
Publicado: (2020)

Neurotrophic Keratopathy and Topical Insulin Therapy: A Case Report
por: Khilji, Maryum, et al.
Publicado: (2023)

Neurotrophic Keratopathy after Trigeminal Nerve Block for Treatment of Postherpetic Neuralgia
por: Kodama-Takahashi, Aya, et al.
Publicado: (2018)

Tear proteomics reveals the molecular basis of the efficacy of human recombinant nerve growth factor treatment for Neurotrophic Keratopathy
por: Pieragostino, Damiana, et al.
Publicado: (2022)

Recombinant Human Nerve Growth Factor (Cenegermin)–Driven Corneal Wound Healing Process: An Evidence-Based Analysis
por: Bonzano, Chiara, et al.
Publicado: (2022)

Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Fleeman, Nigel, et al.
Publicado: (2019)

Clinical outcomes of corneal neurotization using sural nerve graft in neurotrophic keratopathy
por: Saini, Manu, et al.
Publicado: (2023)

Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease?
por: Bruscolini, Alice, et al.
Publicado: (2022)

Prevalence and clinical characteristics of neurotrophic keratopathy in hispanic population in northeastern Mexico
por: Castillo-Macías, Alberto, et al.
Publicado: (2023)

Development of the neurotrophic keratopathy questionnaire: qualitative research
por: Murray, Lindsey T., et al.
Publicado: (2020)

Neurotrophic keratopathy: current challenges and future prospects
por: NaPier, Erin, et al.
Publicado: (2022)

Topical cenegermin associated ocular surface and contact lens drug precipitate deposit formation
por: White, Craig A., et al.
Publicado: (2022)

Neurotrophic Keratopathy in Systemic Diseases: A Case Series on Patients Treated With rh-NGF
por: Meduri, Alessandro, et al.
Publicado: (2022)

A Case of Neurotrophic Keratopathy Associated with Nasopharyngeal Carcinoma
por: Sato, Tomoko, et al.
Publicado: (2018)

A Case of Neurotrophic Keratopathy Concomitant to Brain Metastasis
por: Bonzano, Chiara, et al.
Publicado: (2018)

Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy
por: Dana, Reza, et al.
Publicado: (2021)

Aberrant Corneal Homeostasis in Neurosurgery-Induced Neurotrophic Keratopathy
por: Oba, Shimpei, et al.
Publicado: (2022)

Detection of Subclinical Neurotrophic Keratopathy by Non-Contact Esthesiometry
por: Villalba, Marta, et al.
Publicado: (2023)

Minimally invasive, indirect corneal neurotization using an ipsilateral sural nerve graft for early neurotrophic keratopathy
por: Lee, Brendon W.H., et al.
Publicado: (2022)

Chitosan-based thermosensitive hydrogel with long-term release of murine nerve growth factor for neurotrophic keratopathy
por: Wu, Jie, et al.
Publicado: (2023)

Sclerokeratoplasty as the Therapy for Corneal Perforation due to Exposure and Neurotrophic Keratopathy
por: Rozycki, Radoslaw, et al.
Publicado: (2014)

Vitamin B12 Deficiency as a Cause of Neurotrophic Keratopathy
por: Nassiri, Nader, et al.
Publicado: (2018)

Functional and Structural Changes Following Corneal Neurotisation in the Management of Neurotrophic Keratopathy: UK Single Centre Series
por: Elalfy, Mohamed, et al.
Publicado: (2021)

Neurotrophic Keratopathy after Micropulse Transscleral Cyclophotocoagulation in a Glaucoma Patient
por: Kim, Jonghwa, et al.
Publicado: (2021)

Use of Vivostat PRF® in Acanthamoeba keratitis
por: Marín-Payá, Emma, et al.
Publicado: (2020)

Ipsilateral supraorbital nerve transfer in a case of recalcitrant neurotrophic keratopathy with an intact ipsilateral frontal nerve: A novel surgical technique
por: Jacinto, Frances, et al.
Publicado: (2016)

Bilateral Nerve Alterations in a Unilateral Experimental Neurotrophic Keratopathy Model: A Lateral Conjunctival Approach for Trigeminal Axotomy
por: Yamaguchi, Takefumi, et al.
Publicado: (2013)

The Role of Hi-Tech Devices in Assessment of Corneal Healing in Patients with Neurotrophic Keratopathy
por: Inferrera, Leandro, et al.
Publicado: (2022)

Cyclosporine 0.1% (Ikervis(®)) as a corticoid-sparing agent in Lyell syndrome with KeraKlear(®) keratoprosthesis
por: Rahhal-Ortuño, Miriam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3t9mlogl7eb0dgcj2b2p422pu1